Recently, it has been demonstrated that CTCs from patients with metastatic BC had predominantly mesenchymal phenotypes [25] and that EGF can induce EMT-like effects including the up-regulation of Twist through the EGFR pathway [24], which agree with our experimental data. The gene discussed is EGFR; the disease is breast cancer.